Editorial Responsibility, page-169

"to have put such a massive production and conglomeration as EDE into existence"

That's my point - they haven't. Production, yes, but it's at half-capacity and EDE can't even sell the output from the trial production, let alone CS1. With Q2 approaching the half way mark, there is no sign of improvement.

RE: selling point, I've learnt that's where trend analysis is useful, even for high risk spec stocks like EDE. I did well on the sustained uptrend from 3c onwards, then not so well as it went back down again. Should have sold at 26.5c, which was my "get out" point. Oh well, lesson learnt.